Pharma Companies Welcome New Year With 583 Drug Price Hikes so Far
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Johnson & Johnson Pauses US Varipulse Procedures Amid Safety Review, Investigates Brain-Related Events
Drugs Not Selected for Medicare Price Negotiation Nearly Doubled - Report
TMT Outshone Most Sectors in 2024, Here Is How Well It Performed
Evaluating UnitedHealth Group Against Peers In Health Care Providers & Services Industry
Novo, Eli Lilly to Dominate Global Pharma Sales in 2025: Report
UnitedHealth Urged by Investors to Review Insurance Practices
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
'Medicare Can Now Cover Eli Lilly's Zepbound For Sleep Apnea, CMS Says' - CNBC
Assessing AbbVie: Insights From 17 Financial Analysts
Johnson & Johnson Falls After Pausing Varipulse Cases
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Spotlight on Pfizer: Analyzing the Surge in Options Activity
8 Health Care Stocks Whale Activity In Today's Session
Oak Tree Capital's Marks: New things are prone to bubbles, currently private equity buying S&P 500, with a 10-year yield of only ±2%.
Max recently released a memorandum titled "Revisiting the Bubble," stating that investors are currently betting on the leading high-tech companies to maintain their dominance. However, he believes that it is not easy to stay ahead, as new technologies and competitors can surpass existing market leaders at any time. When people assume that "things can only get better" and Buy based on that, the impact of negative news can be particularly severe. He specifically pointed out the frenzy over AI and how this positive sentiment may spread to other Technology sectors.
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Merck Rival Summit Draws New Buy From Truist on Deal Prospects
Pfizer Analyst Ratings
Sector Update: Health Care Stocks Rise Premarket Wednesday